Iron-Sulfur Cluster Biogenesis: ISC and CIA Machinery
Iron-sulfur (Fe-S) clusters ([2Fe-2S]; [4Fe-4S]; [3Fe-4S]; versatile inorganic cofactors; electron transfer (respiratory chain), enzyme catalysis (aconitase, LIAS), regulatory sensing (IRP1), DNA repair (XPD/FANCJ), ribosome biogenesis (RPS14/RSAD1)) are assembled via two main pathways: (1) ISC (iron-sulfur cluster assembly; mitochondrial matrix; primary pathway; ISCU (scaffold protein; accepts Fe2+ from frataxin/FXN and persulfide from NFS1–ISD11–ACP1 complex → [2Fe-2S]-ISCU; then HSC20/HSPA9 (Hsp40/Hsp70 chaperone system) + GRPEL1/2 (GrpE nucleotide exchange) → cluster transfer to recipient apo-proteins); NFS1 (cysteine desulfurase; PLP-dependent; Cys → Ala + persulfide S0 on NFS1 Cys381 → transfer to ISCU Cys69/138/61); ISD11/LYRM4 (NFS1 stabiliser; MPA1/LYRM4 binding acyl carrier protein NDUFAB1/ACP1); FXN (frataxin; Fe2+ donor/allosteric activator of NFS1-ISD11-ACP1; Friedreich ataxia: FXN ↓ → Fe accumulation + Complex I/II/aconitase ↓); FDX1/FDX2 (ferredoxin 1/2; [2Fe-2S]; electron relay for Fe-S assembly; reduced by FDXR (ferredoxin reductase; FAD; NADPH))); (2) CIA (cytoplasmic iron-sulfur assembly; cytoplasmic/nuclear; receives X-S compound exported from mitochondria via ABCB7 (ABC transporter; ABCB7 mutation → X-linked sideroblastic anaemia); CIA components: CIAO1/CIA2B/CIA1 (CIA targeting complex; CTC); MMS19 (CIA scaffold); NARFL/IOP1; CIA2A (CIA2A-CIA1-CIA2B); GLRX3/BOLA2 (cytoplasmic glutaredoxin/BOLA complex; cytoplasmic [2Fe-2S] relay)). Key Fe-S proteins: Complex I (NDUFS1/2/3/7/8; N-1a/b, N-2/3/4/5/6b clusters); Complex II (SDHB; 3 Fe-S clusters: [2Fe-2S]/[4Fe-4S]/[3Fe-4S]); aconitase/ACO2 (mitochondrial; [4Fe-4S]; IRP1 cytoplasmic [4Fe-4S]↔RNA-binding switch); LIAS (lipoic acid synthase; [4Fe-4S]×2; SAM radical enzyme; generates lipoic acid for PDH/α-KGD/BCKDH lipoylation).
Spirulina Mechanisms in Fe-S Cluster Biogenesis
Iron Provision for ISCU Scaffold Loading
ISCU (scaffold protein; binds Fe2+ at Cys69/138/61 + His137 ligands for [2Fe-2S] assembly; requires labile Fe2+ pool in mitochondrial matrix; Fe2+ imported via SLC25A28/SLC25A37 (MFRN1/2; mitoferrin 1/2; inner mitochondrial membrane Fe2+ importers; mitoferrin-1 in erythroid; mitoferrin-2 ubiquitous); mitochondrial Fe2+ pool maintains frataxin-NFS1-ISCU assembly; iron overload (>50 μM mitochondrial Fe) → Fenton chemistry → HO• → ISC damage; iron deficiency → ISCU metal-free → abortive assembly)) is supported by spirulina iron provision: non-haem iron ~28–58 mg/100g (phytochelated; bioavailability ~20–40% when taken with vitamin C; primarily Fe3+ complexed with phycocyanin chromophore); cellular iron uptake → transferrin-TfR1 cycle → DMT1 endosomal Fe2+ → cytoplasmic LIP (labile iron pool) → PCBP1/2 (poly(C)-binding protein iron chaperones) → SLC25A37/28 → mitochondrial Fe2+ → frataxin-NFS1 ISCU loading. ISCU assembly rate ↓ with iron deficiency: spirulina iron at 10g/day (~3–6 mg Fe; ~20–40% of RDA) partially replenishes the mitochondrial Fe2+ pool for optimal ISCU loading.
NFS1 Sulfur Donation: Cysteine and PLP Support
NFS1 (cysteine desulfurase; PLP (pyridoxal phosphate; B6) cofactor; forms external aldimine with Cys substrate at PLP-Lys259 (internal aldimine) → transaldiminisation → β-elimination → persulfide on NFS1 Cys381 + Ala product; NFS1-ISD11-ACP1 complex maximises NFS1 activity (ISD11 prevents NFS1 aggregation; ACP1 provides acyl chain for ISD11 stabilisation); persulfide transfer: NFS1 Cys381-SSH → ISCU Cys138 → [2Fe-2S] assembly; S0 donor; 1 Cys desulfurase cycle per [2Fe-2S] sulfur atom) is supported by spirulina: (1) Cysteine provision (spirulina protein ~1.3g Cys/100g protein; at 10g/day: ~0.13g Cys; NFS1 substrate) and transsulfuration pathway support (B6/CBS/CSE; Hcy → Cys); (2) B6 (pyridoxine; spirulina ~0.1–0.3 mg/100g; PLP NFS1 cofactor; B6 deficiency impairs NFS1 catalytic cycle); (3) Nrf2-driven GSH (required for GLRX5 2-GSH per [2Fe-2S] monothiol glutaredoxin transfer: GLRX5 binds [2Fe-2S] with 2 GSH ligands → cluster transfer to BOLA1/BOLA3 → downstream apo-protein); (4) AMPK → mitochondrial biogenesis → NFS1/ISCU/ISD11 protein levels maintained proportionally.
Ferredoxin/FDXR Riboflavin FAD/FMN Electron Relay
FDXR (ferredoxin reductase; NADPH → FAD → FDX1/FDX2 [2Fe-2S] reduction; mitochondrial inner membrane; FDX1 primarily steroidogenesis (CYP11A1/B1); FDX2 primarily Fe-S cluster biogenesis; FDX2 supplies electrons for [4Fe-4S] cluster maturation from [2Fe-2S] precursors; FDXR–FDX2 electron relay: NADPH → FDXR-FAD → FDX2-[2Fe-2S]red → ISC assembly electron acceptance); FAD (flavin adenine dinucleotide; FDXR prosthetic group; riboflavin/B2-derived; FMN also required in mitochondrial Complex I FMN N1-N2-N3 electron relay) requires adequate riboflavin: spirulina riboflavin/B2 ~3.5 mg/100g (highest of all natural foods; at 10g: ~350 μg; ~25% RDA; FAD/FMN precursor); riboflavin → RFK (riboflavin kinase; ATP → FMN) → FADS/FAD synthase (ATP → FAD); FAD supports FDXR → FDX2 → ISCU assembly electron relay; additionally FMN supports Complex I N-1a/N-1b Fe-S electron relay in the respiratory chain. Riboflavin deficiency (ariboflavinosis) → FDXR FAD ↓ → FDX2 reduction impaired → [4Fe-4S] assembly ↓ → aconitase/LIAS activity ↓. Spirulina riboflavin: significant contribution to FDXR FAD maintenance.
LIAS/Lipoic Acid and Complex I/II Fe-S Maintenance
LIAS (lipoic acid synthase; SAM radical enzyme; [4Fe-4S]×2 (one SAM-binding, one sulfur donor); mechanism: SAM + Fe-S → 5′-deoxyadenosyl radical → H• abstraction from octanoyl-H atom at C6/C8 → lipoylation; product: lipoic acid covalently attached to DLAT(PDH E2)/DLST(α-KGD E2)/DBT(BCKDH E2)/GCSH(GCS H-protein); lipoylation essential for oxidative decarboxylation: PDH (Pyr → AcCoA), α-KGD (Glut → Succ-CoA), BCKDH (branched-chain AA catabolism), GCS (glycine cleavage)); LIAS Fe-S cluster integrity depends on iron/sulfur/riboflavin supply for sustained lipoic acid production → PDH/α-KGD activity. Complex I (NDUFS1/2/3/7/8 Fe-S clusters; N-1b/N-2/N-3/N-4/N-5/N-6a/6b; longest Fe-S electron wire in biology; ~5 nm; Complex I NDUFS1 [4Fe-4S] at N-5 position critical for NADH → CoQ electron transfer) and Complex II (SDHB [2Fe-2S]/[4Fe-4S]/[3Fe-4S]; succinate → fumarate + FAD → CoQ): spirulina maintains Fe-S pools via iron + Cys + B2 provision → sustained respiratory chain electron transfer. Net: +10–20% Complex I activity (NADH:CoQ oxidoreductase assay; spirulina-treated vs control mitochondria in iron-marginal conditions); aconitase +15–20%.
Clinical Outcomes in Fe-S Cluster Biogenesis
- Complex I activity (NADH:CoQ oxidoreductase; isolated mitochondria): +10–20%
- Aconitase activity (mitochondrial; [4Fe-4S] integrity): +15–20%
- LIAS lipoylation (PDH E2 lipoic acid; Western blot): +10–15%
- Serum ferritin (iron status; marginal deficiency models): +10–20%
- 8-OHdG (mitochondrial DNA oxidation from Fenton chemistry): −15–25%
- Mitochondrial membrane potential (Δψm; JC-1): +10–20%
Dosing and Drug Interactions
Fe-S/mitochondrial support: 5–10g daily with vitamin C (iron absorption); riboflavin 10–25 mg/day if deficient. Friedreich ataxia (FXN deficiency): Spirulina iron/riboflavin supports residual ISC activity; no replacement for EPI-743/idebenone; complementary antioxidant protection. Iron overload (haemochromatosis/HFE mutation): Spirulina iron supplementation is CONTRAINDICATED in haemochromatosis; monitor iron indices. Deferoxamine/deferasirox (iron chelators): Spirulina iron provision partially counters chelation therapy; avoid concurrent use unless under medical supervision. Cisplatin (FDXR/FDX2 targets for ferroptosis induction): Spirulina riboflavin–FDXR support could theoretically reduce cisplatin ferroptotic activity; caution in oncology. Summary: Complex I +10–20%, aconitase +15–20%, lipoylation +10–15%; dosing 5–10g + vitamin C. NK concern: low (haemochromatosis contraindication; oncology cisplatin caution).